Revisão Revisado por pares

Commentary about papular mycosis fungoides, lymphomatoid papulosis and lymphomatoid pityriasis lichenoides: more similarities than differences

2015; Wiley; Volume: 43; Issue: 4 Linguagem: Inglês

10.1111/cup.12653

ISSN

1600-0560

Autores

Eric C. Vonderheid, Marshall E. Kadin, Gladys H. Telang,

Tópico(s)

Fungal Infections and Studies

Resumo

Journal of Cutaneous PathologyVolume 43, Issue 4 p. 303-312 Perspectives in Dermatopathology Commentary about papular mycosis fungoides, lymphomatoid papulosis and lymphomatoid pityriasis lichenoides: more similarities than differences Eric C. Vonderheid, Corresponding Author Eric C. Vonderheid Sidney Kimmel Cancer Center, Johns Hopkins Medical Institutes, Baltimore, MD, USA Eric Vonderheid, MD, Sidney Kimmel Cancer Center, Johns Hopkins Medical Institutes, 37580 S. Desert Sun Drive, Tucson, AZ 85739, USA Tel: +520-825-2699 Fax: +410 614 0635 e-mail: [email protected]Search for more papers by this authorMarshall E. Kadin, Marshall E. Kadin Department of Dermatology, Boston University and Roger Williams Medical Center, Providence, RI, USASearch for more papers by this authorGladys H. Telang, Gladys H. Telang Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, RI, USASearch for more papers by this author Eric C. Vonderheid, Corresponding Author Eric C. Vonderheid Sidney Kimmel Cancer Center, Johns Hopkins Medical Institutes, Baltimore, MD, USA Eric Vonderheid, MD, Sidney Kimmel Cancer Center, Johns Hopkins Medical Institutes, 37580 S. Desert Sun Drive, Tucson, AZ 85739, USA Tel: +520-825-2699 Fax: +410 614 0635 e-mail: [email protected]Search for more papers by this authorMarshall E. Kadin, Marshall E. Kadin Department of Dermatology, Boston University and Roger Williams Medical Center, Providence, RI, USASearch for more papers by this authorGladys H. Telang, Gladys H. Telang Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, RI, USASearch for more papers by this author First published: 14 November 2015 https://doi.org/10.1111/cup.12653Citations: 15Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Zackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. J Am Acad Dermatol 2002; 47: 914. 2Nashan D, Faulhaber D, Ständer S, Luger TA, Stadler R. Mycosis fungoides: a dermatological masquerader. Br J Dermatol 2007; 156: 1. 3Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 1994; 18: 645. 4Reddy K, Bhawan J. Histologic mimickers of mycosis fungoides: a review. J Cutan Pathol 2007; 34: 519. 5Sarantopoulos GP, Palla B, Said J, et al. Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol 2013; 139: 536. 6Arps DP, Chen S, Fullen DR, Hristov AC. Selected inflammatory imitators of mycosis fungoides: histologic features and utility of ancillary studies. Arch Pathol Lab Med 2014; 138: 1319. 7Allen AC. Persistent "insect bites" (dermal eosinophilic granulomas) simulating lymphoblastomas, histiocytoses, and squamous cell carcinomas. Am J Pathol 1948; 24: 367. 8Rijlaarsdam JU, Scheffer E, Meijer CJ, Willemze R. Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients. Cancer 1992; 69: 717. 9Magro CM, Crowson AN, Kovatich AJ, Burns F. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells. Hum Pathol 2003; 34: 119. 10Bagot M, Wechsler J, Lescs MC, Revuz J, Farcet JP, Gaulard P. Intraepidermal localization of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992; 27: 589. 11Fivenson DP, Hanson CA, Nickoloff BJ. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma. J Am Acad Dermatol 1994; 31(5 Pt 1): 717. 12Gellrich S, Lukowsky A, Schilling T, et al. Microanatomical compartments of clonal and reactive T cells in mycosis fungoides: molecular demonstration by single cell polymerase chain reaction of T cell receptor gene rearrangements. J Invest Dermatol 2000; 115: 620. 13Cerroni L, Arzberger E, Ardigò M, Pütz B, Kerl H. Monoclonality of intraepidermal T lymphocytes in early mycosis fungoides detected by molecular analysis after laser-beam-based microdissection. J Invest Dermatol 2000; 114: 1154. 14Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol 2005; 53: 1053. 15van Haselen CW, Diederen PV, Toonstra J, et al. The small-cell variant of mycosis fungoides. A clinicopathological and quantitative electron microscopic study on 14 patients. Arch Dermatol Res 1998; 290: 583. 16Nasu K, Said J, Vonderheid E, Olerud J, Sako D, Kadin ME. Immunopathology of cutaneous T-cell lymphomas. Am J Pathol 1985; 119: 436. 17Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, Vejlsgaard GL. Immunophenotypic studies in cutaneous T-cell lymphomas: clinical implications. Br J Dermatol 1993; 129: 655. 18Wood GS, Abel EA, Hoppe RT, Warnke RA. Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. J Am Acad Dermatol 1986; 14: 1006. 19Michie SA, Abel EA, Hoppe RT, Warnke RA, Wood GS. Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. Am J Pathol 1990; 137: 1447. 20Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713. 21Bergman R. How useful are T-cell receptor gene rearrangement studies as an adjunct to the histopathologic diagnosis of mycosis fungoides? Am J Dermatopathol 1999; 21: 498. 22Dippel E, Assaf C, Hummel M, et al. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol 1999; 188: 146. 23Lukowsky A, Richter S, Dijkstal K, Sterry W, Muche JM. A T-cell receptor gamma polymerase chain reaction assay using capillary electrophoresis for the diagnosis of cutaneous T-cell lymphomas. Diagn Mol Pathol 2002; 11: 59. 24Ponti R, Quaglino P, Novelli M, et al. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 2005; 153: 565. 25Cerroni L, Arzberger E, Ardigò M, Pütz B, Kerl H. Monoclonality of intraepidermal T lymphocytes in early mycosis fungoides detected by molecular analysis after laser-beam-based microdissection. J Invest Dermatol 2000; 114: 1154. 26Dereure O, Levi E, Vonderheid EC, Kadin ME. Improved sensitivity of T-cell clonality detection in mycosis fungoides by hand microdissection and heteroduplex analysis. Arch Dermatol 2003; 139: 1571. 27Yazdi AS, Medeiros LJ, Puchta U, Thaller E, Flaig MJ, Sander CA. Improved detection of clonality in cutaneous T-cell lymphomas using laser capture microdissection. J Cutan Pathol 2003; 30: 486. 28Thurber SE, Zhang B, Kim YH, Schrijver I, Zehnder J, Kohler S. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J Am Acad Dermatol 2007; 57: 782. 29Ponti R, Fierro MT, Quaglino P, et al. TCR gamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol 2008; 128: 1030. 30Sufficool KE, Lockwood CM, Abel HJ, et al. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides. J Am Acad Dermatol 2015; 73: 228. 31Reinhold U, Herpertz M, Kukel S, Oltermann I, Uerlich M, Kreysel HW. Induction of nuclear contour irregularity during T-cell activation via the T-cell receptor/CD3 complex and CD2 antigens in the presence of phorbol esters. Blood 1994; 83: 703. 32Reinhold U, Liu L, Sesterhenn J, Abken H. CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells. Immunology 1996; 89: 391. 33Reinhold U, Abken H. CD4+ CD7- T cells: a separate subpopulation of memory T cells? J Clin Immunol 1997; 17: 265. 34Vonderheid EC, Bigler RD, Kotecha A, et al. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). J Invest Dermatol 2001; 117: 654. 35Payne CM, Spier CM, Grogan TM, et al. Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell. Am J Dermatopathol 1988; 10: 377. 36Moll M, Reinhold U, Kukel S, et al. CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol 1994; 102: 328. 37Kodama K, Fink-Puches R, Massone C, Kerl H, Cerroni L. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides. J Am Acad Dermatol 2005; 52: 694. 38Vonderheid EC, Kadin ME. Papular mycosis fungoides: a variant of mycosis fungoides or lymphomatoid papulosis? J Am Acad Dermatol 2006; 55: 177. 39Uddin A, Bennett M, Nayeem K, Marren P, Abushaira H. A case of papular mycosis fungoides: new clinical variant of early mycosis fungoides. J Eur Acad Dermatol Venereol 2007; 21: 685. 40Martorell-Calatayud A, Botella-Estrada R, Sanmartín-Jimenez O, Requena C, Guillén-Barona C, Sangüeza OP. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides. J Cutan Pathol 2010; 37: 330. 41Liu ZH, Wang YL, Chen SY, et al. Papular mycosis fungoides: a new clinic variant of early and benign mycosis fungoides? J Clin Oncol 2011; 29: e381. 42Neri I, D'Acunto C, Pileri A, Reggiani C, Patrizi A. Papular mycosis fungoides: a new case expanding the spectrum of phenotypic and clinical findings. G Ital Dermatol Venereol 2011; 146: 505. 43Noe MH, Drake A, Link BK, Liu V. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal. J Cutan Pathol 2013; 40: 714. 44Brajon D, Bonnet N, Dales JP, Berbis P. Papular mycosis fungoides. Ann Dermatol Venereol 2013; 140: 455. 45Santamarina-Albertos A, Muñoz-Martínez R, Alvarez-Gago T, Miranda-Romero A. Papular mycosis fungoides on the legs: a case report. Actas Dermosifiliogr 2014; 105: 87. 46Balta I, Akbay G, Eksioglu M, Astarcı M, Ekiz O. Papular mycosis fungoides: a case report and review in the literature. Indian J Dermatol 2015; 60: 107. 47Kempf W, Kazakov DV, Kerl K. Cutaneous lymphomas: an update. Part 1: T-cell and natural killer/t-cell lymphomas and related conditions. Am J Dermatopathol 2014; 36: 105. 48Kadin M, Nasu K, Sako D, Said J, Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol 1985; 119: 315. 49Ralfkiaer E, Stein H, Wantzin GL, Thomsen K, Ralfkiaer N, Mason DY. Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies. Am J Clin Pathol 1985; 84: 587. 50Kaudewitz P, Stein H, Burg G, Mason DY, Braun-Falco O. Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol 1986; 86: 350. 51Wood GS, Strickler JG, Deneau DG, Egbert B, Warnke RA. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation. J Am Acad Dermatol 1986; 15: 444. 52Chott A, Vonderheid EC, Olbricht S, Miao NN, Balk SP, Kadin ME. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 1996; 106: 696. 53Paulli M, Berti E, Rosso R, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin – clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995; 13: 1343. 54Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653. 55Liu HL, Hoppe RT, Kohler S, Harvell JD, Reddy S, Kim YH. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol 2003; 49: 1049. 56Kunishige JH, McDonald H, Alvarez G, Johnson M, Prieto V, Duvic M. Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Clin Exp Dermatol 2009; 34: 576. 57Gan EY, Tang MB, Tan SH. Lymphomatoid papulosis: is a second lymphoma commoner among East Asians? Clin Exp Dermatol 2012; 37: 118. 58de Souza A, el-Azhary RA, Camilleri MJ, Wada DA, Appert DL, Gibson LE. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol 2012; 66: 928. 59El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004; 140: 441. 60Edinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH. CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol 2009; 33: 1860. 61Humme D, Lukowsky A, Steinhoff M, et al. Dominance of nonmalignant T-cell clones and distortion of the TCR repertoire in the peripheral blood of patients with cutaneous CD30+ lymphoproliferative disorders. J Invest Dermatol 2009; 129: 89. 62Saggini A, Gulia A, Argenyi Z, et al. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases. Am J Surg Pathol 2010; 34: 1168. 63Plaza JA, Feldman AL, Magro C. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases. J Cutan Pathol 2013; 40: 236. 64Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol 2006; 55: 557. 65Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment. Am J Clin Dermatol 2007; 8: 29. 66Sharon VR, Konia TH, Barr KL, Fung MA. Assessment of the 'no eosinophils' rule: are eosinophils truly absent in pityriasis lichenoides, connective tissue disease, and graft-vs.-host disease? J Cutan Pathol 2012; 39: 413. 67Rivitti EA. Pityriasis lichenoides: review of cases seen in two major dermatology centers in San Paulo, Brazil, 1977 to 1989. In Miller SA, ed., Parapsoriasis. Proceedings of the First International Parapsoriasis Symposium, Rochester, MN , 14–17. 68Weinman VF, Ackerman AB. Lymphomatoid papulosis. A critical review and new findings. Am J Dermatopathol 1981; 3: 129. 69Willemze R, Scheffer E. Clinical and histologic differentiation between lymphomatoid papulosis and pityriasis lichenoides. J Am Acad Dermatol 1985; 13: 418. 70Giannetti A, Girolomoni G, Pincelli C, Benassi L. Immunopathologic studies in pityriasis lichenoides. Arch Dermatol Res 1988; 280(Suppl): S61. 71Varga FJ, Vonderheid EC, Olbricht SM, Kadin ME. Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Am J Pathol 1990; 136: 979. 72Shieh S, Mikkola DL, Wood GS. Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica. Arch Dermatol 2001; 137: 305. 73Jang KA, Choi JC, Choi JH. Expression of cutaneous lymphocyte-associated antigen and TIA-1 by lymphocytes in pityriasis lichenoides et varioliformis acuta and lymphomatoid papulosis: immunohistochemical study. J Cutan Pathol 2001; 28: 453. 74Tomasini D, Tomasini CF, Cerri A, et al. Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases. J Cutan Pathol 2004; 31: 531. 75Wenzel J, Gütgemann I, Distelmaier M, et al. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides. J Am Acad Dermatol 2005; 53: 422. 76Solomon GJ, Magro CM. Foxp3 expression in cutaneous T-cell lymphocytic infiltrates. J Cutan Pathol 2008; 35: 1032. 77Kim JE, Yun WJ, Mun SK, et al. Pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica: comparison of lesional T-cell subsets and investigation of viral associations. J Cutan Pathol 2011; 38: 649. 78Magro C, Crowson AN, Kovatich A, Burns F. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol 2002; 33: 788. 79Magro CM, Crowson AN, Morrison C, Li J. Pityriasis lichenoides chronica: stratification by molecular and phenotypic profile. Hum Pathol 2007; 38: 479. 80Dereure O, Levi E, Kadin ME. T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol 2000; 136: 1483. 81Weinberg JM, Kristal L, Chooback L, Honig PJ, Kramer EM, Lessin SR. The clonal nature of pityriasis lichenoides. Arch Dermatol 2002; 138: 1063. 82Black MM, Marks R. The inflammatory reaction in pityriasis lichenoides. Br J Dermatol 1972; 87: 533. 83Black MM, Jones EW. "Lymphomatoid" pityriasis lichenoides: a variant with histological features simulating a lymphoma. A clinical and histopathological study of 15 cases with details of long term follow up. Br J Dermatol 1972; 86: 329. 84Ko JW, Seong JY, Suh KS, Kim ST. Pityriasis lichenoides-like mycosis fungoides in children. Br J Dermatol 2000; 142: 347. 85Wang SH, Hsiao CH, Hsiao PF, Chu CY. Adult pityriasis lichenoides-like mycosis fungoides with high density of CD8-positive T-lymphocytic infiltration. J Eur Acad Dermatol Venereol 2007; 21: 401. 86Cho EB, Youn SH, Park EJ, Kwon IH, Kim KH, Kim KJ. CD8-positive pityriasis lichenoides-like mycosis fungoides. Eur J Dermatol 2012; 22: 415. 87de Unamuno BB, Ferriols AP, Sánchez RB, et al. Adult pityriasis lichenoides-like mycosis fungoides: a clinical variant of mycosis fungoides. Int J Dermatol 2014; 53: 1331. 88Kempf W, Kazakov DV, Palmedo G, Fraitag S, Schaerer L, Kutzner H. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases. Am J Surg Pathol 2012; 36: 1021. 89Sim JH, Kim YC. CD8+ lymphomatoid papulosis. Ann Dermatol 2011; 23: 104. 90Wen PF, Jia L, Zhang M, Li GD, Liu WP, Wang L. Lymphomatoid papulosis type D in a Chinese young man: a newly recognized variant. Chin Med J (Engl) 2013; 126: 3997. 91McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis. J Cutan Pathol 2014; 41: 88. 92Wu H, Telang GH, Lessin SR, Vonderheid EC. Mycosis fungoides with CD30-positive cells in the epidermis. Am J Dermatopathol 2000; 22: 212. 93Fortson JS, Schroeter AL, Esterly NB. Cutaneous T-cell lymphoma (parapsoriasis en plaque). An association with pityriasis lichenoides et varioliformis acuta in young children. Arch Dermatol 1990; 126: 1449. 94Panizzon RG, Speich R, Dazzi H. Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphomas of the skin. Dermatology 1992; 184: 65. 95Thomson KF, Whittaker SJ, Russell-Jones R, Charles-Holmes R. Childhood cutaneous T-cell lymphoma in association with pityriasis lichenoides chronica. Br J Dermatol 1999; 141: 1146. 96Tomasini D, Zampatti C, Palmedo G, Bonfacini V, Sangalli G, Kutzner H. Cytotoxic mycosis fungoides evolving from pityriasis lichenoides chronica in a seventeen-year-old girl. Report of a case. Dermatology 2002; 205: 176. 97Kempf W, Kutzner H, Kettelhack N, Palmedo G, Burg G. Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia. Br J Dermatol 2005; 152: 1327. 98Boccara O, Blanche S, de Prost Y, Brousse N, Bodemer C, Fraitag S. Cutaneous hematologic disorders in children. Pediatr Blood Cancer 2012; 58: 226. 99Vonderheid EC, Kadin ME, Gocke CD. Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis? Am J Dermatopathol 2011; 33: 835. 100Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program 2005; 231. 101Guitart J, Martinez-Escala ME, Deonizio JM, Gerami P, Kadin ME. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes. J Am Acad Dermatol 2015; 72: 508. 102Sarris AH, Daliani D, Ulmer R, et al. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas. Clin Cancer Res 1997; 3: 169. 103Tensen CP, Vermeer MH, van der Stoop PM, et al. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol 1998; 111: 222. 104Burg G, Dummer R, Haeffner A, Kempf W, Kadin M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 2001; 137: 949. 105Burg G, Dummer R, Nestle FO, Doebbeling U, Haeffner A. Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol 1996; 132: 567. 106Dereure O, Levi E, Vonderheid EC, Kadin ME. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 2002; 118: 949. 107Kandolf Sekulović L, Cikota B, Jović M, et al. The role of apoptosis and cell-proliferation regulating genes in mycosis fungoides. J Dermatol Sci 2009; 55: 53. 108Wang Y, Su M, Zhou LL, et al. Deficiency of SATB1 expression in Sézary cells causes apoptosis resistance by regulating FasL/CD95L transcription. Blood 2011; 117: 3826. 109Stutz N, Johnson RD, Wood GS. The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis. J Am Acad Dermatol 2012; 67: 1327. 110Gu X, Wang Y, Zhang G, Li W, Tu P. Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis. J Dermatol 2013; 40: 596. 111Huang Y, Su MW, Jiang X, Zhou Y. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma. Blood 2015; 125: 1435. 112Wu J, Salva KA, Wood GS. c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death. J Invest Dermatol 2015; 135: 861. 113Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 1995; 19: 1423. 114Santucci M, Biggeri A, Feller AC, Massi D, Burg G. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol 2000; 24: 40. 115Naraghi ZS, Seirafi H, Valikhani M, Farnaghi F, Kavusi S, Dowlati Y. Assessment of histologic criteria in the diagnosis of mycosis fungoides. Int J Dermatol 2003; 42: 45. 116Inchara YK, Rajalakshmi T. Early mycosis fungoides vs. inflammatory mimics: how reliable is histology? Indian J Dermatol Venereol Leprol 2008; 74: 462. Citing Literature Volume43, Issue4April 2016Pages 303-312 ReferencesRelatedInformation

Referência(s)